Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.80 CNY
691.88 M CNY
11.93 B CNY
695.64 M
About SHANGHAI SHYNDEC PHARMACEUTICAL
Sector
Headquarters
Shanghai
Founded
1996
Website
ISIN
CNE000001JG2
FIGI
BBG000BWJ5N9
Shanghai Shyndec Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and sale of pharmaceutical products. Its products include anti-infective, cardiovascular, nervous system, respiratory, anticancer and Immunomodulator drugs. The company was founded in 1996 and is headquartered in Shanghai, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 600420 is 12.68 CNY — it has decreased by −0.16% in the past 24 hours. Watch SHANGHAI SHYNDEC PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange SHANGHAI SHYNDEC PHARMACEUTICAL stocks are traded under the ticker 600420.
600420 stock has fallen by −1.40% compared to the previous week, the month change is a 4.71% rise, over the last year SHANGHAI SHYNDEC PHARMACEUTICAL has showed a 23.83% increase.
We've gathered analysts' opinions on SHANGHAI SHYNDEC PHARMACEUTICAL future price: according to them, 600420 price has a max estimate of 19.52 CNY and a min estimate of 19.52 CNY. Watch 600420 chart and read a more detailed SHANGHAI SHYNDEC PHARMACEUTICAL stock forecast: see what analysts think of SHANGHAI SHYNDEC PHARMACEUTICAL and suggest that you do with its stocks.
600420 reached its all-time high on Jun 4, 2015 with the price of 30.33 CNY, and its all-time low was 1.23 CNY and was reached on Jul 11, 2005. View more price dynamics on 600420 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
600420 stock is 1.35% volatile and has beta coefficient of 1.43. Track SHANGHAI SHYNDEC PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is SHANGHAI SHYNDEC PHARMACEUTICAL there?
Today SHANGHAI SHYNDEC PHARMACEUTICAL has the market capitalization of 17.03 B, it has increased by 1.84% over the last week.
Yes, you can track SHANGHAI SHYNDEC PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
SHANGHAI SHYNDEC PHARMACEUTICAL is going to release the next earnings report on Mar 28, 2025. Keep track of upcoming events with our Earnings Calendar.
600420 net income for the last quarter is 236.05 M CNY, while the quarter before that showed 387.22 M CNY of net income which accounts for −39.04% change. Track more SHANGHAI SHYNDEC PHARMACEUTICAL financial stats to get the full picture.
SHANGHAI SHYNDEC PHARMACEUTICAL dividend yield was 1.02% in 2023, and payout ratio reached 18.41%. The year before the numbers were 1.10% and 16.36% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 22, 2024, the company has 11.61 K employees. See our rating of the largest employees — is SHANGHAI SHYNDEC PHARMACEUTICAL on this list?
Like other stocks, 600420 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI SHYNDEC PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANGHAI SHYNDEC PHARMACEUTICAL technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANGHAI SHYNDEC PHARMACEUTICAL stock shows the buy signal. See more of SHANGHAI SHYNDEC PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.